Axon Enterprise, Inc $AXON Shares Acquired by ProShare Advisors LLC

Posted by Brenda Bartman on Nov 2nd, 2026

ProShare Advisors LLC boosted its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 9.6% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 95,647 shares of the biotechnology company’s stock after acquiring an additional 8,362 shares during the quarter. ProShare Advisors LLC’s holdings in Axon Enterprise were worth $40,413,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently added to or reduced their stakes in the company. Keating Financial Advisory Services Inc. purchased a new position in shares of Axon Enterprise in the 2nd quarter worth about $31,000. Washington Trust Advisors Inc. lifted its stake in shares of Axon Enterprise by 1,300.0% in the 2nd quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after purchasing an additional 65 shares in the last quarter. M & L Capital Management Ltd purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $30,000. Wealth Enhancement Trust Services Inc. purchased a new stake in shares of Axon Enterprise during the 3rd quarter worth about $33,000. Finally, Delos Wealth Advisors LLC acquired a new stake in Axon Enterprise during the 2nd quarter worth approximately $45,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Analyst Ratings Changes

AXON has been the topic of several research reports. Northcoast Research raised their price target on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a research note on Tuesday, July 21st. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. Barclays raised their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, Citigroup reissued a “market outperform” rating on shares of Axon Enterprise in a research note on Monday. One investment analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $688.38.

View Our Latest Stock Analysis on AXON

Insider Activity

In other news, insider Jeffrey Kunins sold 9,605 shares of the business’s stock in a transaction on Friday, August 21st. The shares were sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the transaction, the insider directly owned 97,761 shares of the company’s stock, valued at approximately $61,266,818.70. The trade was a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of the company’s stock in a transaction on Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the transaction, the president owned 296,974 shares of the company’s stock, valued at $170,590,774.82. This trade represents a 5.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 47,397 shares of company stock valued at $26,722,984. 4.20% of the stock is currently owned by company insiders.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $427.77 on Monday. The company has a market cap of $34.75 billion, a P/E ratio of 177.50, a PEG ratio of 8.13 and a beta of 1.44. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a one year low of $339.01 and a one year high of $749.96. The business’s 50-day simple moving average is $463.44 and its 200 day simple moving average is $481.21.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm had revenue of $904.39 million during the quarter, compared to analysts’ expectations of $876.42 million. During the same quarter in the prior year, the business earned $2.12 EPS. Axon Enterprise’s quarterly revenue was up 35.3% compared to the same quarter last year. On average, sell-side analysts forecast that Axon Enterprise, Inc will post 2.10 earnings per share for the current fiscal year.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: An analyst opinion upgraded Axon Enterprise to “Buy,” arguing that the company’s valuation premium has narrowed and that its integrated public-safety hardware and cloud-software ecosystem continues to support strong growth. Axon Enterprise: Upgrading To Buy As The Premium Fades
Positive Sentiment: Recent comparisons with DocuSign, Adobe and Datadog highlighted Axon’s rapid expansion in public safety and its combination of connected devices, software and recurring services. Other coverage also raised the possibility of substantial long-term upside, though these articles were opinion-based rather than new company announcements. Can Axon Stock Jump 50?
Neutral Sentiment: Investment comparisons positioned Axon as a high-growth public-safety technology company, but offered no new financial results, contracts or guidance that would immediately change earnings expectations. Axon Enterprise vs. DocuSign
Negative Sentiment: Investors may be reducing exposure before earnings because Zacks said Axon does not appear to have the usual combination of factors supporting a likely earnings beat. That raises the risk of volatility if results or guidance fall short of expectations. Axon Reports Next Week
Negative Sentiment: Concerns remain that employee share-based compensation taxes are consuming cash despite strong growth, while the stock’s premium valuation leaves limited room for execution errors. Strong Growth, But Staff Share Taxes Eat The Cash
Negative Sentiment: Axon’s larger decline than the broader market indicates near-term selling pressure, likely reflecting profit-taking and pre-earnings caution rather than a newly announced operational setback. Axon Registers a Bigger Fall Than the Market

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.